(2R,3S)-2-(7-Benzyloxy-naphthalen-2-ylmethyl)-N*1*-((S)-1-carbamoyl-2-phenyl-ethyl)-3,N*4*-dihydroxy-succinamide

ID: ALA265763

Chembl Id: CHEMBL265763

PubChem CID: 44337525

Max Phase: Preclinical

Molecular Formula: C31H31N3O6

Molecular Weight: 541.60

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](Cc1ccc2ccc(OCc3ccccc3)cc2c1)[C@H](O)C(=O)NO

Standard InChI:  InChI=1S/C31H31N3O6/c32-29(36)27(17-20-7-3-1-4-8-20)33-30(37)26(28(35)31(38)34-39)16-22-11-12-23-13-14-25(18-24(23)15-22)40-19-21-9-5-2-6-10-21/h1-15,18,26-28,35,39H,16-17,19H2,(H2,32,36)(H,33,37)(H,34,38)/t26-,27+,28+/m1/s1

Standard InChI Key:  GNWXHESPUNJCNK-PKTNWEFCSA-N

Associated Targets(Human)

FCER2 Tchem Immunoglobulin epsilon Fc receptor (92 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MMP1 Tchem Matrix metalloproteinase-1 (7046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 541.60Molecular Weight (Monoisotopic): 541.2213AlogP: 2.66#Rotatable Bonds: 12
Polar Surface Area: 150.98Molecular Species: NEUTRALHBA: 6HBD: 5
#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 6#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.61CX Basic pKa: CX LogP: 3.07CX LogD: 3.04
Aromatic Rings: 4Heavy Atoms: 40QED Weighted: 0.14Np Likeness Score: -0.01

References

1. Bailey S, Bolognese B, Faller A, Louis-Flamberg P, MacPherson DT, Mayer RJ, Marshall LA, Milner PH, Mistry J, Smith DG, Ward JG..  (1999)  Selective inhibition of low affinity IgE receptor (CD23) processing: P1' bicyclomethyl substituents.,  (21): [PMID:10560745] [10.1016/s0960-894x(99)00552-1]

Source